Endocrine and pituitary disorders
Clinical research in acromegaly focuses on long-term disease control, symptom management, and the use of somatostatin analogue therapies in chronic endocrine care.
- Acromegaly
- Hormonal excess management
- Pituitary-related treatment
These studies reflect sustained interest in therapies used to regulate growth hormone-related disorders and associated clinical burden.
Neuroendocrine tumours
Research activity includes treatment evaluation in gastroenteropancreatic neuroendocrine tumors, with attention to tumour control and progression-free survival in advanced disease.
- Gastroenteropancreatic neuroendocrine tumors
- Tumour progression control
- Somatostatin receptor-directed therapy
The therapeutic focus in this area is on managing well-differentiated, unresectable, and metastatic disease through targeted endocrine oncology approaches.
Hepatic and cystic disease
Studies in polycystic liver disease examine effects on liver volume and symptom burden, supporting investigation of medical options for patients with enlarged cystic livers.
- Polycystic liver disease
- Liver enlargement
- Symptomatic cystic disease
This area highlights interest in therapies that address structural liver involvement and related clinical manifestations.
Metabolic and weight-related therapy
Clinical development also extends to body weight management, including work on semaglutide-based depot formulations aimed at metabolic treatment settings.
- Body weight management
- Metabolic disorders
- GLP-1-based therapy
These investigations place emphasis on therapeutic strategies for weight regulation within broader endocrine and metabolic care.
